Literature DB >> 30224871

Validity and Reliability of the Turkish Version of the Questionnaire for the Assessment of Dysphagia in Multiple Sclerosis.

Elif Gökçe Tenekeci1, BelgüZar Kara2, Ahmet Çetiz3, Şeref Demirkaya3, Numan Demir4, Cengizhan Açikel5.   

Abstract

INTRODUCTION: The aim of this study was to investigate the validity and reliability of the Turkish version of the Questionnaire for the Assessment of DYsphagia in MUltiple Sclerosis (DYMUS) that has been developed for evaluating dysphagia in patients with multiple sclerosis.
METHODS: This methodological study was conducted in the neurology clinic and outpatient department of a training hospital between March 15 and September 15, 2015. The study included 117 patients aged 18 years and over who had a definite diagnosis of multiple sclerosis, could communicate in Turkish, and volunteered to be included. Data were collected using a descriptive information form, the DYMUS, and the Eating Assessment Tool (EAT-10). The scale was translated and back translated to determine the language validity, and a specialist was consulted to make sure the content was valid. We used the EAT-10 and Kurtzke's Expanded Disability Status Scale (EDSS) concurrently to test the criterion-related validity. The test-retest procedure was used at 1-week intervals for 37 patients in this study. Descriptive statistics, factor analysis, Kappa analysis, reliability analysis, and correlation analysis were used to analyze the data.
RESULTS: Factor analysis revealed that the scale was bifactorial, and this was consistent with its original form. There were positive and statistically significant relationships between the DYMUS and EAT-10 (r=0.90, p<0.001) and the mean EDSS scores (r=0.49, p<0.001). The internal consistency of the total scale was high (Cronbach's alpha coefficient= 0.91). The Cronbach's alpha coefficients pertaining to dysphagia for solids and liquids were determined to be 0.88 and 0.83, respectively. The total scale and subscales demonstrated a high test-retest reliability (r=0.79-0.95, p<0.001).
CONCLUSION: In this study, the Turkish version of the DYMUS was found to be a valid and reliable tool for evaluating dysphagia in patients with multiple sclerosis.

Entities:  

Keywords:  Dysphagia; mutiple sclerosis; reliability; validity

Year:  2016        PMID: 30224871      PMCID: PMC6138226          DOI: 10.5152/npa.2016.18105

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  14 in total

1.  Health Beliefs Related to Salt-Restricted Diet in Patients on Hemodialysis: Psychometric Evaluation of the Turkish Version of the Beliefs About Dietary Compliance Scale.

Authors:  Belgüzar Kara
Journal:  J Transcult Nurs       Date:  2013-12-31       Impact factor: 1.959

2.  Oropharyngeal dysphagia in multiple sclerosis.

Authors:  Marziyeh Poorjavad; Fatemeh Derakhshandeh; Masoud Etemadifar; Bahram Soleymani; Alireza Minagar; Amir-Hadi Maghzi
Journal:  Mult Scler       Date:  2010-03       Impact factor: 6.312

3.  Swallowing abnormalities in multiple sclerosis: correlation between videofluoroscopy and subjective symptoms.

Authors:  W Wiesner; S G Wetzel; L Kappos; M M Hoshi; U Witte; E W Radue; W Steinbrich
Journal:  Eur Radiol       Date:  2001-09-05       Impact factor: 5.315

4.  [Oropharyngeal dysphagia in patients with multiple sclerosis].

Authors:  R Terré-Boliart; F Orient-López; D Guevara-Espinosa; S Ramón-Rona; M Bernabeu-Guitart; P Clavé-Civit
Journal:  Rev Neurol       Date:  2004 Oct 16-31       Impact factor: 0.870

5.  Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.

Authors:  Roberto Bergamaschi; C Rezzani; S Minguzzi; M P Amato; F Patti; Maria Giovanna Marrosu; S Bonavita; M G Grasso; Angelo Ghezzi; M Rottoli; C Gasperini; D Restivo; D Maimone; Paolo Rossi; M L Stromillo; C Montomoli; C Solaro
Journal:  Funct Neurol       Date:  2009 Jul-Sep

6.  Validity and reliability of the Eating Assessment Tool (EAT-10).

Authors:  Peter C Belafsky; Debbie A Mouadeb; Catherine J Rees; Jan C Pryor; Gregory N Postma; Jacqueline Allen; Rebecca J Leonard
Journal:  Ann Otol Rhinol Laryngol       Date:  2008-12       Impact factor: 1.547

7.  Dysphagia in multiple sclerosis.

Authors:  A De Pauw; E Dejaeger; B D'hooghe; H Carton
Journal:  Clin Neurol Neurosurg       Date:  2002-09       Impact factor: 1.876

Review 8.  Dysphagia in multiple sclerosis: from pathogenesis to diagnosis.

Authors:  Cristina Tassorelli; Roberto Bergamaschi; Simona Buscone; Michelangelo Bartolo; Anna Furnari; Paola Crivelli; Enrico Alfonsi; Elisa Alberici; Giulia Bertino; Giorgio Sandrini; Giuseppe Nappi
Journal:  Neurol Sci       Date:  2008-12       Impact factor: 3.307

9.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

10.  Translation, cross-cultural adaptation and validation of the Portuguese version of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.

Authors:  Déborah S Sales; Regina Mp Alvarenga; Claudia Cf Vasconcelos; Roberta G Silva; Luiz Cs Thuler
Journal:  Springerplus       Date:  2013-07-22
View more
  2 in total

1.  Validation of the Persian version of the dysphagia in multiple sclerosis questionnaire for the assessment of dysphagia in multiple sclerosis.

Authors:  Faezeh Asadollahpour; Azar Mehri; Ahmadreza Khatoonabadi; Fereshteh Mohammadzaheri; Abbas Ebadi
Journal:  J Res Med Sci       Date:  2019-06-25       Impact factor: 1.852

2.  Screening of dysphagia in relapsing-remitting multiple sclerosis patients in Montenegro.

Authors:  Jevto Lj Eraković; Ljiljana B Radulović; Zilha A Idrizović; Milovan B Roganović
Journal:  Neurosciences (Riyadh)       Date:  2021-10       Impact factor: 0.735

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.